glp 1 and tamoxifen SABCS 2025: Can GLP-1s Help People With Breast Cancer? glp-1_analogs [TUSOM | Pharmwiki]

This article explores what makes the GLP1 receptor such a powerful therapeutic target and how it affects multiple organ systems

however, other factors, such as side effects and route of administration (most all GLP1 receptor agonists are administered via subcutaneous injection) can also contribute to patients discontinuing their GLP1 receptor agonists

Dosing starts at 3 mg daily for 30 days, then increases to 7 mg, with a maximum of 14 mg daily based on glycaemic response and tolerability

This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists

As patients lose fat mass, they become more metabolically healthy, reducing strain on multiple organs

This is also the window where you can genuinely assess whether the medication is working for you